Natrol, Plethico to merge in $80.8 million deal
CHATSWORTH, Calif. Natrol on Sunday announced the signing of a definitive merger agreement with Plethico Pharmaceuticals of India in a stock-purchase deal worth approximately $80.8 million.
“We are pleased to announce this transaction which culminates a process initiated and directed by our board of directors to maximize value for our stockholders,” said Wayne Bos, Natrol president and chief executive officer. “We have gained a solid reputation in our market niches and believe the merger with Plethico will also be a win-win for our customers and employees.”
Natrol expects the tender offer to be commenced on Nov. 27.
Enzymatic launches ActiFruit cranberry supplement
KEARNY, N.J. Enzymatic Therapy recently announced the launch of its ActiFruit line with Cran-Max Cranberry Supplements, including both a one-per-day soft chew and 30-count capsules.
“ActiFruit with Cran-Max delivers the ultra-concentrated power of cranberries in an easy, one-per-day dose,” stated Matt Schueller, senior vice president of marketing for Enzymatic Therapy. “The ActiFruit chews are a break-through product. It’s rare to find a supplement that’s really effective, but tastes like a delicious fruit treat.”
“Cran-Max is the only cranberry supplement supported by two published studies and is the first one-per-day supplement on the market,” stated Dean Mosca, president of Proprietary Nutritionals, the company that markets Cran-Max.
According to the company, one ActiFruit soft chew equals the antioxidant power of seven glasses of cranberry juice cocktail. The supplement supports bladder and urinary tract health and fights free radicals with beneficial antioxidants.
PacificHealth announces Jonny Bowden as spokesperson for Satiatrim
MATAWAN, N.J. PacificHealth Laboratories on Tuesday announced that Jonny Bowden, a board-certified nutrition specialist and a nationally known expert on weight loss and nutrition, has agreed to become a spokesperson for Satiatrim, a new 50-calorie diet drink that the company claims reduces eating by up to 20 percent when consumed before a meal.
“[Bowden] brings a wealth of experience and unmatched credibility in the weight loss arena to the Satiatrim brand,” stated Robert Portman, chief executive officer of PacificHealth Laboratories. “With his track record of providing millions of men and women with science-based weight-loss solutions, consumers are sure to take Dr. Bowden seriously when he talks about the benefits of Satiatrim.”
Bowden is author of “Living the Low-Carb Life: Choosing the Diet that’s Right for You from Atkins to Zone.”
His next book, “The Most Effective Natural Cures on Earth,” will be published by Fair Winds Press in January 2008.